Syngene International to Host Conference Call for Q4 and Full Year FY2026 Results
The management team of Syngene International Limited (Syngene) will organize a conference call for Analysts and Investors to discuss the financial results for the quarter and full year ended March 2026.The conference call is scheduled for Thursday, April 30, 2026, at 2:00 pm IST. The session will begin with a brief management discussion regarding the Q4 and full year FY2026 performance, followed by an interactive Question & Answer session with participants.
Details concerning the conference call are provided below:
| Detail | Information |
|---|---|
| Date | Thursday, April 30, 2026 |
| Time | 2:00 pm to 3:00 pm IST |
| Primary Dial-in Number | +91 22 6280 1279 / 91 22 7115 8180 |
| International Numbers | USA - 18667462133, UK - 08081011573, Singapore - 8001012045, Hong Kong - 800964448, Australia - 0080014243444 |
Participants can also join the event via webcast using the provided link. A replay facility will be available from April 30, 2026, till May 7, 2026.
About Syngene International Ltd.
Syngene International Ltd. is an integrated research, development, and manufacturing services company. It serves the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.Syngene's operations are supported by a team of over 8,300 employees, including more than 5,700 scientists. The company aims to deliver scientific excellence and world-class manufacturing, robust data security, and faster time-to-market to improve the cost of innovation.
The company operates with over 3 million sq. ft of specialized discovery, development, and manufacturing facilities across India and the U.S. Syngene works with approximately 400 global customers across various industry segments, including biotech companies and multinationals such as BMS, GSK, Zoetis, and Merck KGaA.
Syngene International Ltd. can be identified by the following market codes:
| Exchange | Code / Symbol | ISIN |
|---|---|---|
| BSE | 539268 | INE 398R01022 |
| NSE | SYNGENE | INE 398R01022 |
SYNGENE Stock Price Movement
Shares of Syngene International Limited today slipped by 1.74% to settle at ₹435.95. The stock traded on high volume, handling 744,277 shares through the day's session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.